-transparent.png){kind=logo}
Historically, the terms partial (PGD) and mixed gonadal dysgenesis (MGD) have been used to describe incomplete testicular differentiation in individuals with 46,XY or 45,X/46,XY karyotypes, respectively. However, it is currently unclear to what extent clinical features actually differ between these individuals. The aim of this study was to compare clinical, laboratory, and histological findings in these 2 groups. Patients with testicular dysgenesis seen in our service between 1989 and 2013 were selected. Sixty-one patients met the inclusion criteria. Individuals with 46,XY and 45,X/46,XY karyotypes were compared regarding genital features, gonadal histology and function, growth, and associated conditions. Twenty-five had mosaicism with a 45,X cell line (MGD), while a 46,XY karyotype (PGD) was found in 36 cases belonging to 32 families. Mutations in NR5A1, WT1, and SRY genes associated with testicular dysgenesis were found in 12 families. There were no significant differences regarding parental consanguinity, degree of external androgenization, gonadal location, histology, and function, and associated conditions. However, in the MGD group, the presence of a uterus, lower birth weight and length, and short stature were more often observed. Therefore, the use of histological features to classify PDG and MGD should be abandoned and replaced by classification based on karyotype.
Juliana G R Andrade, and
Helena Fabbri-Scallet, and
Ana P Dos Santos, and
Martine Cools, and
Ralf Werner, and
Olaf Hiort, and
Maricilda P de Mello, and
Gil Guerra-Júnior, and
Andrea T Maciel-Guerra
January 1969,
Annales d'endocrinologie,
Juliana G R Andrade, and
Helena Fabbri-Scallet, and
Ana P Dos Santos, and
Martine Cools, and
Ralf Werner, and
Olaf Hiort, and
Maricilda P de Mello, and
Gil Guerra-Júnior, and
Andrea T Maciel-Guerra
March 2010,
Arquivos brasileiros de endocrinologia e metabologia,
Juliana G R Andrade, and
Helena Fabbri-Scallet, and
Ana P Dos Santos, and
Martine Cools, and
Ralf Werner, and
Olaf Hiort, and
Maricilda P de Mello, and
Gil Guerra-Júnior, and
Andrea T Maciel-Guerra
November 1970,
Annals of internal medicine,
Juliana G R Andrade, and
Helena Fabbri-Scallet, and
Ana P Dos Santos, and
Martine Cools, and
Ralf Werner, and
Olaf Hiort, and
Maricilda P de Mello, and
Gil Guerra-Júnior, and
Andrea T Maciel-Guerra
March 2024,
American journal of medical genetics. Part A,
Juliana G R Andrade, and
Helena Fabbri-Scallet, and
Ana P Dos Santos, and
Martine Cools, and
Ralf Werner, and
Olaf Hiort, and
Maricilda P de Mello, and
Gil Guerra-Júnior, and
Andrea T Maciel-Guerra
January 1994,
Indian journal of pediatrics,
Juliana G R Andrade, and
Helena Fabbri-Scallet, and
Ana P Dos Santos, and
Martine Cools, and
Ralf Werner, and
Olaf Hiort, and
Maricilda P de Mello, and
Gil Guerra-Júnior, and
Andrea T Maciel-Guerra
March 1983,
The Journal of reproductive medicine,
Juliana G R Andrade, and
Helena Fabbri-Scallet, and
Ana P Dos Santos, and
Martine Cools, and
Ralf Werner, and
Olaf Hiort, and
Maricilda P de Mello, and
Gil Guerra-Júnior, and
Andrea T Maciel-Guerra
January 1999,
Hormone research,
Juliana G R Andrade, and
Helena Fabbri-Scallet, and
Ana P Dos Santos, and
Martine Cools, and
Ralf Werner, and
Olaf Hiort, and
Maricilda P de Mello, and
Gil Guerra-Júnior, and
Andrea T Maciel-Guerra
August 2021,
Journal of obstetrics and gynaecology of India,
Juliana G R Andrade, and
Helena Fabbri-Scallet, and
Ana P Dos Santos, and
Martine Cools, and
Ralf Werner, and
Olaf Hiort, and
Maricilda P de Mello, and
Gil Guerra-Júnior, and
Andrea T Maciel-Guerra
April 1984,
Clinical genetics,
Juliana G R Andrade, and
Helena Fabbri-Scallet, and
Ana P Dos Santos, and
Martine Cools, and
Ralf Werner, and
Olaf Hiort, and
Maricilda P de Mello, and
Gil Guerra-Júnior, and
Andrea T Maciel-Guerra
January 2009,
Genetic counseling (Geneva, Switzerland),
